IP Library › Granted Patent US 9,884,808
Granted Patent B2
US 9,884,808 · App. 14/430,155 · Granted Feb 6, 2018

Preparation of an intermediate compound of ioforminol

Inventors: Mikkel Jacob Thaning, Jr. (Oslo, NO); Andreas Olsson (Oslo, NO); Christian Glogard (Oslo, NO)
Assignee: GE Healthcare AS
C07C231/14C07C231/02C07C231/24C07C237/46
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,884,808
App. No.
14/430,155
Granted
Feb 6, 2018
Kind
B2
Abstract

The present invention relates to a process for the preparation of iodinated X-ray contrast agents and in particular to key intermediates thereof. More particularly, the invention relates to a work-up process for preparation of a compound mixture comprising 1-formylamino-3,5-bis(2,3-bis(formyloxy)propan-1-ylcarbamoyl)-2,4,6-trioodobenzene, a key intermediate in the process for preparing Ioforminol. Further, the invention relates to a process for preparing Ioforminol, a contrast agent useful in X-ray imaging.

Claims (30)

1. A process for the preparation of a compound mixture (3) as a powder, wherein the compound mixture (3) comprises two or more compounds of formula (3)

wherein each X individually denotes hydrogen, a formyl group (—CO—H) or an acetyl group (—CO—CH 3 ), said process comprising:

i) formylating the amino function of 5-amino-N 1 ,N 3 -bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (compound (4)) in the presence of a mixed anhydride comprising an acetyl group to form a product solution;

ii) adding isopropanol in situ to the product solution of step i) to form a slurry comprising precipitated compound mixture (3), wherein the concentration of isopropanol is about 0.5 to 1.0 mL per gram of compound (4) and the slurry of step (ii) is stirred for 5-25 hours; and

iii) collecting the precipitated compound mixture (3) by filtration.

2. The process of claim 1 , further comprising seeding the product solution of step i) with compound mixture (3) before adding isopropanol.

3. The process of claim 1 , wherein the concentration of the isopropanol is about 0.6 to about 0.7 ml per gram of compound (4).

4. The process of claim 1 , wherein the amount of isopropanol used in step ii) is added in one portion and the process further comprises a step of washing the compound mixture (3) collected in step iii) with one or more portions of isopropanol.

5. The process of claim 1 , wherein the compound mixture (3) prepared by the process has a purity of >99%.

6. A process for preparing Ioforminol from a compound mixture (3), the process comprising preparing compound mixture (3) according to the process of claim 1 , hydrolyzing compound mixture (3) to form a compound (2), wherein all X in formula (3) are H, and

dimerizing compound (2) to form Ioforminol.

7. The process of claim 1 , wherein the slurry of step ii) is stirred for 10-20 hours.

8. The process of claim 1 , wherein the compound mixture (3) comprises 0-7 wt % isopropanol.

9. A process for the preparation of a compound mixture (3) as a powder, wherein the compound mixture (3) comprises two or more compounds of formula (3)

wherein each X individually denotes hydrogen, a formyl group (—CO—H) or an acetyl group (—CO—CH 3 ), said process comprising:

i) formylating the amino function of 5-amino-N 1 ,N 3 -bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide (compound (4)) in the presence of a mixed anhydride comprising an acetyl group to form a product solution;

ii) adding a short chain alcohol in situ to the product solution of step i) to form a slurry comprising precipitated compound mixture (3), wherein the concentration of the short chain alcohol is about 0.3 to 2.0 mL per gram of compound (4) and the slurry of step (ii) is stirred for 5-25 hours; and

iii) collecting the precipitated compound mixture (3) by filtration;

wherein the short chain alcohol is C1-C6 straight or branched, mono hydroxylated or di hydroxylated, or a mixture thereof.

10. The process of claim 9 , further comprising seeding the product solution of step i) with compound mixture (3) before adding the short chain alcohol.

11. The process of claim 9 , wherein the concentration of the short chain alcohol is about 0.5 to about 1.0 ml per gram of compound (4).

12. The process of claim 9 , wherein the amount of short chain alcohol used in step ii) is added in one portion and the process further comprises a step of washing the compound mixture (3) collected in step iii) with one or more portions of the short chain alcohol.

13. The process of claim 9 , wherein the compound mixture (3) in powder form as prepared by the process has a purity of >99%.

14. A process for preparing Ioforminol from a compound mixture (3), the process comprising preparing compound mixture (3) according to the process of claim 9 , hydrolyzing compound mixture (3) to form a compound (2), wherein all X in formula (3) are H, and

dimerizing compound (2) to form Ioforminol.

15. The process of claim 9 , wherein the slurry of step ii) is stirred for 10-20 hours.

16. The process of claim 9 , wherein the compound mixture (3) comprises 0-7 wt % short chain alcohol.

17. The process of claim 9 , wherein the short chain alcohol is methanol.

18. The process of claim 9 , wherein the short chain alcohol is ethanol.

19. The process of claim 9 , wherein the short chain alcohol is 1-propanol.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2015
From: THANING, MIKKEL; OLSSON, ANDREAS; GLOGARD, CHRISTIAN
To: GE HEALTHCARE AS
Reel/Frame 035243/0769 →
Priority Claims (1)
NO 20121102 · Sep 27, 2012 · national
Continuity (1)
Related Publication 20150246871A1 · Sep 3, 2015